Clin2
NCT04792931Possibly a fitRecruiting

Study for adults with suspected autoimmune muscle disease

Idiopathic Inflammatory Myopathies

Part of Bones, joints & muscles, Brain & nervous system clinical trials.

This study looks at adults who may have an autoimmune (self-immune) muscle disease. It aims to better understand and evaluate this condition, which may help guide future diagnosis and care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • A clinician suspects you have an inflammatory autoimmune muscle problem
  • You have social security coverage/affiliation
  • You can understand the study and give informed consent
  • You are not pregnant or breastfeeding
  • You are able and willing to participate in the research

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06306547Not yet recruiting
Inflammatory myositis study for adults

This study follows people with inflammatory myositis over time to learn more about the condition. If you join, you may receive closer monitoring and contribute to research that could improve future treatments.

NCT03092180Recruiting
Tests a treatment approach for certain muscle inflammation diseases

This trial looks at treatment strategies for people with idiopathic inflammatory myopathies, which are illnesses where the immune system attacks muscles. It may help improve how treatment is chosen and optimized for this group of conditions, but it specifically excludes several related muscle diseases.

São Paulo
NCT07284797Recruiting· Phase 1
Safety study for autoimmune disease and healthy volunteers

This trial is testing an experimental drug for safety in people with certain autoimmune diseases—like myositis, scleroderma, or Sjögren's disease—as well as in healthy volunteers. It aims to find out if the drug is safe enough to study further.

Melbourne
NCT07789015Not yet recruiting· Phase 3
Testing a new drug for active inflammatory muscle disease

This trial tests a new drug called nerandomilast in people with active inflammatory muscle disease (myositis) that is not well controlled with current treatments. It aims to see if the drug can improve muscle strength and overall disease activity.

Phoenix, Arizona
NCT00017914Recruiting
Understanding muscle inflammation: adult and juvenile myositis study

This research study helps doctors better understand myositis—a group of rare diseases that cause muscle inflammation and weakness. Researchers collect blood samples, medical history, and sometimes muscle biopsies to learn more about what causes these conditions and how to treat them better.

Atlanta, Georgia
NCT05454527Recruiting
Biobank study follow-up for adults with inflammatory muscle disease

This study follows adults who have (or are being evaluated for) inflammatory muscle conditions to collect health data and genetic test information. It may help researchers better understand these diseases and improve future care.

Paris

Hear when a new Idiopathic Inflammatory Myopathies trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.